On April 22, 2026, BrainsWay Ltd (BWAY) shares rose 3.4% today, bringing the current price to $15.85. The stock has seen significant upward movement in the past
Brainsway (BWAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Brainsway Ltd. Sponsored ADR (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CDNL, BWAY and CENX are three stocks defying market weakness, with strong price momentum amid geopolitical turmoil.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Brainsway (BWAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
BrainsWay has delivered strong revenue growth, expanding its leasing model and recurring revenue base. BWAY reported 27% annual revenue growth, 75.4% gross margin, and issued 2026 guidance for $66–68M revenue and $12–14M adjusted EBITDA. The leasing model drives high-margin, stable recurring revenue with 93% customer retention and $70M in remaining performance obligations.
Brainsway Ltd. Sponsored ADR (NASDAQ: BWAY - Get Free Report) shares hit a new 52-week high during trading on Wednesday following a stronger than expected earnings report. The company traded as high as $13.75 and last traded at $13.29, with a volume of 102207 shares. The stock had previously closed at $12.71. The company reported $0.14
BrainsWay stock rises after Optum expands Deep TMS coverage for adolescents, boosting reimbursement visibility.
BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript
BrainsWay Ltd. ( BWAY ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Hadar Levy - Chief Executive Officer Ido Marom - Chief Financial Officer Conference Call Participants Brian Ritchie - Lifesci Advisors, LLC Jeffrey Cohen - Ladenburg Thalmann & Co. Inc., Research Division Carl Byrnes - Northland Capital Markets, Research Division Raghuram Selvaraju - H.C.
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.